Phase Iv Clinical Trials - Vaccines

Relevant Publications

Trends in Overall Survival in Lung Adenocarcinoma with EFGR Mutation, KRAS Mutation, or No Mutation.

Issue Release: 2025

Pharmacological effects, formulations, and clinical research progress of curcumin.

Issue Release: 2025

Chinese herbal formula Tongxie Yaofang granules for diarrhoea-predominant irritable bowel syndrome: a randomised, double-blind, placebo-controlled, phase II trial.

Issue Release: 2025

Clozapine for Treatment-Resistant Disruptive Behaviors in Youths With Autism Spectrum Disorder Aged 10-17 Years: Protocol for an Open-Label Trial.

Issue Release: 2025

Optimal bevacizumab treatment strategy in advanced ovarian cancer: A review.

Issue Release: 2025

Abatacept and the risk of malignancy: a meta-analysis across disease indications.

Issue Release: 2025

Safety profile of efgartigimod from global clinical trials across multiple immunoglobulin G-mediated autoimmune diseases.

Issue Release: 2025

Intravenous branched-chain amino acid administration for the acute treatment of hepatic encephalopathy: a systematic review and meta-analysis.

Issue Release: 2025

Anti-viral action against type 1 diabetes autoimmunity: The GPPAD-AVAnT1A study protocol.

Issue Release: 2025

Protocol for the development and validation of a Core Set for exercise-based rehabilitation of adults with multiple long-term conditions (multimorbidity) based on the World Health Organization\'s International Classification of Functioning, Disability, and Health (ICF) framework.

Issue Release: 2025

TREOCAPA: prophylactic treatment of the ductus arteriosus in preterm infants by acetaminophen-statistical analysis plan for the randomized phase III group sequential trial.

Issue Release: 2025

Allogeneic Stem Cell Transplantation in Participants With Hematologic Malignancies Following Pembrolizumab Therapy.

Issue Release: 2025

Camrelizumab-based therapies for the treatment of advanced lung cancer: a prospective, open-label, multicenter, observational, real-world study.

Issue Release: 2025

Safety Extension Study of Edaravone Oral Suspension in Patients With Amyotrophic Lateral Sclerosis for up to an Additional 96 Weeks of Treatment.

Issue Release: 2025

Patterns of SARS-CoV-2-specific humoral and cellular immune response in actively treated patients with solid cancer following prime BNT162b2 COVID-19 vaccination: results from phase IV CoVigi trial.

Issue Release: 2025

Advances on cancer vaccine trials registered in China and the USA in 2014-2024.

Issue Release: 2025

Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: study protocol of the SUNSTAR randomised controlled open-label superiority trial.

Issue Release: 2025

Systematic literature review of intravenous versus subcutaneous administration of oncology therapies: A clinical, economic and patient perspective.

Issue Release: 2025

The Role of Intravenous Selexipag in Managing PAH and Bridging Gaps in Oral Treatment: A Narrative Review.

Issue Release: 2025

A systematic review of maternal and perinatal health outcomes in the context of epidemic threats: towards the development of a core outcome set.

Issue Release: 2025

What are the Protocols for Safe Vaccine Administration?

Why are Some Pathogens Challenging to Vaccinate Against?

Can Vaccines Fail to Protect?

What are Proteins in Vaccines?

How Are Pneumococcal Vaccines Administered?

Why is GIS Important for Vaccine Surveillance?

How Effective is the Tetanus Vaccine?

What Should You Do if You Suspect Vaccine-Related Paralysis?

Why is the HPV Vaccine Important?

What is the Future of Vaccination Programs?

Phase Iv Clinical Trials - Vaccines

Relevant Publications

Partnered Content Networks

Relevant Topics